1. Ebselen (2-phenyl-1,2-benzisoselenazol-3(2H)-one) is a non-toxic se
leno-organic drug with antiinflammatory, antiatherosclerotic and cytop
rotective properties. 2. Ebselen and some of its metabolites are effec
tive reductants of hydroperoxides including those arising in biomembra
nes and lipoproteins. 3. By reactions with hydroperoxides and thiols s
everal interconversion cycles are formed which include ebselen metabol
ites with varying oxidation number of the selenium. 4. In the presence
of thiols ebselen mimics the catalytic activities of phospholipid hyd
roperoxide glutathione peroxidase. 5. Ebselen inhibits at low concentr
ations a number of enzymes involved in inflammation such as lipoxygena
ses, NO synthases, NADPH, oxidase, protein kinase C and H+/K+-ATPase.
The inhibitions are manifested on the cellular level and may contribut
e to the antiinflammatory potential of ebselen.